From the Michael Heidelberger Division of Immunology, Department of Pathology and Kaplan
Comprehensive Cancer Center, New York University Medical Center, New York 10016
It is well established that B7-CD28/CTLA4 interactions play an important role in the induction of T helper cells for T-dependent antibody responses. However, targeted mutation of
CD28 does not significantly affect production of IgG and activation of CD4 T helper cells in
response to infections by some viruses and nematode parasites. To test whether the CD28-independent induction of Ig class switches requires costimulation by the heat-stable antigen (HSA), we compared T helper cell induction and antibody response in mice deficient for either
HSA, CD28, or both genes. We found that after immunization with KLH-DNP, mice deficient for both CD28 and HSA lack DNP-specific IgA and all subtypes of IgG. This deficiency
corresponds to a reduced number of effector helper T cells that rapidly produce IL-2, IL-4, and
IFN-
after in vitro stimulation with carrier antigen KLH. In contrast, priming of T helper
cells and Ig class switch are normal in mice deficient with either HSA or CD28 alone. IgM responses are not affected by any of these targeted mutations. These results demonstrate that
CD28-independent induction of T helper cells and Ig class-switches requires costimulation by
the HSA.
 |
Introduction |
Immunological help from T cells to B cells is essential for
the induction of antibody class switching and B cell
memory. Since induction of T cell help requires costimulation by the antigen-presenting cells (1), lack of proper costimulation leads to defective T cell-dependent antibody
response (2, 3). For some antigens (2, 4), substantial defects
in Ig class switches and memory of T cell-dependent antibody responses have been reported in mice with a targeted
mutation of CD28 gene that encodes for a major receptor
for B7 family of costimulatory molecules (5). Interestingly, the extent of defects varies depending on the types of antigens used. For instance, IgG responses to NIP (hydroxy-iodo-nitrophenyl-acetyl)-coupled chicken gamma globulin
and goat anti-mouse IgD are severely reduced in CD28-deficient mice (2, 4), whereas blockade of B7-CD28/ CTLA4 interaction only marginally affects IgG responses in
mice infected with viruses such as lymphocytic choriomeningitis virus (LCMV) (6, 7) and vesicular stomatitis (VSV)
(7), or a nematode parasite, Heligmosomoides polygyrus (4).
Two hypotheses can be invoked to explain the CD28-independent IgG responses. First, T cells specific for the
antigens can be activated by TCR ligand in the absence of
costimulation. Second, activation of T cells specific for
these antigens requires costimulation provided by other costimulatory molecules. Recent studies from several laboratories including ours have demonstrated that multiple costimulatory molecules, such as the heat-stable antigen
(HSA; references 8), CD48 (14, 15), CD44H (16), intercellular adhesion molecule 1 (ICAM-1; references 17,
18), and 4-1BB ligand (19, 20) can promote T cell activation in a number of experimental models. It is therefore
plausible that these costimulators may compensate for the
CD28-deficiency. We are especially interested in the role
of HSA in CD28-deficient mice, as we and others have established that this molecule plays a critical role in the induction of T cell clonal expansion (8), CTL maturation
(10), and induction of CD8 T cell memory (12, 13).
To test whether CD28-independent induction of immunological help for CD4 T cells requires costimulation by
HSA, we compared activation of T helper cells as well as
T-dependent antibody responses in wild-type mice to
those in mice that are deficient of CD28 alone, HSA alone,
and both HSA and CD28. Our results demonstrated that
after immunization with DNP-coupled KLH, mice deficient for both HSA and CD28 failed to produce DNP-specific IgG1, IgG2a, IgG2b, IgG3, and IgA. This deficiency
correlates with a defective induction of antigen-specific cytokine-producing cells. In contrast, substantial IgG1, IgG2a,
and IgG2b responses and cytokine-producing cells are
present in mice that are deficient for either CD28 or HSA.
Thus, CD28-independent induction of T helper function
and Ig class switches require costimulation by the HSA.
 |
Materials and Methods |
Experimental Animals.
Mice deficient for CD28 gene (6) were
provided by Dr. Tak Mak (University of Toronto, Toronto, Ontario, Canada); those deficient for HSA (21) were a gift from Dr.
Peter Nielsen (Max Planck Institut fur Immunologie, Freiburg,
Germany), and those deficient for both HSA and CD28 were
produced as previously described (12). CD28-deficient mice have
been backcrossed to C57BL6/j for six generations, while the
HSA-deficient mice were produced using ES cells from
C57BL6/j mice, as described. C57BL6/j mice purchased from
the National Cancer Institute (Rockville, MD) were used as controls. Mice between 6 and 16 wk of age were used for the study.
Immunization and Measurement of DNP-specific Antibody Responses.
Age- and sex-matched mice were immunized intraperitoneally
with 50 µg/mouse of DNP-KLH (Sigma Chemical Co., St.
Louis, MO) in CFA. Sera were collected at day 7 after the primary immunization. The immunized mice were boosted with 50 µg
of KLH-DNP in IFA at 2 wk after the primary immunization,
and the sera were collected at 2 wk after the second immunization, as indicated in Fig. 1. 1 mo after the second immunization,
mice were killed and the spleen cells were harvested for ELISA
spot assay (Fig. 1).

View larger version (8K):
[in this window]
[in a new window]
|
Fig. 1.
Experimental scheme. Age- and sex-matched mice were immunized intraperitoneally with 50 µg/mouse of DNP-KLH in CFA. Sera
were collected at 1 wk after the primary immunization. The immunized
mice were boosted with 50 µg of KLH-DNP in IFA at 2 wk after the
primary immunization, and the sera were collected 2 wk after the second
immunization. At 1 mo after the second immunization, mice were killed
and the spleen cells were harvested for ELISA spot assay.
|
|
DNP-specific antibodies were detected by an indirect ELISA.
In brief, MicroTest IIITM Flexible Assay Plates (Falcon®, Oxnard,
CA) were coated with 1 µg/ml of either BSA or BSA-DNP (50 µl/well) at 4°C overnight, after blocking with 10% FCS in PBS,
the plates were washed five times with PBS containing 0.1% Tween 20. Varying dilutions of mouse sera were added and incubated for 2 h. The classes and subclasses of the DNP-specific antibodies, namely, IgM, IgA (Sigma Chemical Co.), IgG1, IgG2a
(PharMingen, San Diego, CA), IgG2b, and IgG3 (Southern Biotechnology Associates, Birmingham, AL) were determined using
horseradish peroxidase (HRP)-conjugated, subtype-specific antibodies according the manufacturer's instructions.
ELISA Spot Assay to Detect Cytokine-producing Cells.
We used
antibody pairs from PharMingen to detect cytokine-producing
cells using MultiscreenTM 96-well filtration plates (MAHA S45
10; Millipore, France). In brief, the filtration plates were coated
with purified mAbs specific for either IL-2 (JES6-1A12), IL-4
(BVD4-1D11), or IFN-
(R46A2) (2 µg/ml, 100 µl/well) at
4°C overnight. After blocking with 10% FCS-PBS and washing
with PBS, varying numbers of spleen cells from either naive mice
or mice that had been immunized twice with KLH-DNP were
added to the wells. For APCs we used T cell-depleted, mitomycin
C-treated spleen cells from C57BL6/j mice (2 × 105/well). KLH
or medium control was added before overnight incubation. The
cells were washed away using PBS-0.1% Tween 20. Biotinylated mAbs specific for either IL-2 (JES6-5H4), IL-4 (BVD6.24G2), or IFN-
(XMG1.2) were added. HRP-labeled avidin (PharMingen)
and its substrate 3-amino-9-ethylcarbazole were used to visualize the cytokine-producing spots.
Induction of CD40L on CD4 T Cells from Different Strains of
Mice.
We used a previously published protocol (22) to detect
maximal level of induced CD40L on CD4 T cells. In brief, spleen
cells (3 × 106/ml) from primed mice were stimulated with anti-CD3 mAb for 4 h in the presence of PE-labeled anti-CD40L
mAb MR-1 (1µg/ml, PharMingen). The unbound mAb was
washed away, while the CD4 T cells were marked using FITC-labeled anti-CD4 mAb (PharMingen). To verify the specificity of
the PE-MR1 staining, we used 100-fold excess of unlabeled
MR-1 or control HB224 mAb to block the staining.
 |
Results and Discussion |
Targeted Mutation of HSA Ablates CD28-independent Antibody Class Switching.
Previous studies from several laboratories have established that although targeted mutation of
CD28 ablates germinal center formation and Ig class
switching to some antigens (2, 4), IgG responses to infectious antigens tested, such as LCMV, VSV, and nematode
parasites, were largely unaffected (4, 6, 7). Moreover,
priming of CD4 T cells by KLH is only marginally affected (2). To determine whether CD28-independent Ig class
switch depends on the HSA, we immunized congenic mice
with KLH-DNP and measured the quantity and isotypes of
DNP-specific antibodies, as depicted in Fig. 1. As shown in
Fig. 2 A, 1 wk after primary immunization, strong anti-DNP IgM responses were detected in all four strains of
mice. Thus, mutations of HSA and/or CD28 do not significantly affect the T cell-independent antibody responses. Moreover, since the DNP-specific B cells are present in all
four strains of mice, neither HSA nor CD28 is required for
the development of B cells specific for DNP. In wild-type
mice and those with a targeted mutation of either HSA or
CD28, IgG2b and IgG3 responses were quite substantial after one immunization. However, IgG2b and IgG3 were
not detectable in mice deficient for both CD28 and HSA
(Fig. 2, B and C). DNP-specific IgG1, IgG2a, and IgA
were barely detectable in all four strains of mice tested after
the primary immunization (data not shown).

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 2.
Quantity and isotypes of DNP-specific antibodies 1 wk after
primary immunization, as determined by ELISA. Data presented are
means and SD of OD 492 as a relative measure for the amount of antibodies that binds to DNP-BSA-coated plates. Antibody bindings to BSA-coated plates were insignificant and were not presented. Five age- and
sex-matched mice were used in each group. Data are representative of
five independent experiments with two to five mice per group.
|
|
After a boost, IgM, IgA, and all subclasses of IgG were
present at high levels in wild-type mice and in mice with
a targeted mutation of either HSA or CD28. However,
no anti-DNP IgG and IgA antibodies were detected in
mice deficient for both HSA and CD28 (Fig. 3). Thus,
CD28-independent Ig class switch requires costimulation by the HSA.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 3.
Quantity and isotypes of DNP-specific antibodies 1 wk after second immunization, as determined by ELISA. Mice used in experiments described in Fig. 2 were boosted, and their sera Ig determined. See Fig. 2 legend for details. Data are representative of five independent experiments with
two to five mice per group.
|
|
HSA Is Necessary for CD28-independent Induction of Carrier
Specific, Cytokine-producing Helper T Cells.
Since Ig class
switch requires T cell help, we investigated the defects in T
helper cell induction in mice with targeted mutation of
both HSA and CD28. Previous studies have established
that T cells help antibody class switch by at least two mechanisms. First, antigen-specific T cells express CD40L upon
engagement of antigen, and the CD40L then interact with
CD40 on B cells to deliver immunological help (23). Second, activated T cells produce a number of cytokines to induce antibody class switch in B cells. Deficiency in CD40 or CD40L leads to a severely reduced antibody class-switch
(for review see reference 24), whereas lack of response to
given cytokines affects selective isotypes of antibodies produced (for review see references 24). To determine
whether the CD40L induction on CD4 T cells is affected
by deficiency in HSA and CD28, we stimulated T cells by
anti-CD3 in the presence of PE-labeled anti-CD40L mAb. We have previously demonstrated that this method allows
rapid detection of high levels of CD40L after engagement
of TCR-CD3 complex (22). As shown in Fig. 4, a-d, anti-CD3 induced a comparable amount of CD40L on CD4 T
cells from wild-type and HSA-deficient mice. Although
the expression of CD40L is somewhat lower in CD28-deficient mice, mutations of both HSA and CD28 did not
lead to further reduction in CD40L expression. The specificity of the CD40L staining on CD4 T cells is verified, as
unlabeled anti-CD40L mAb significantly blocked the binding of PE-labeled anti-CD40L (data not shown). Thus, costimulation by HSA is neither necessary nor sufficient for
CD40L induction on CD4 T cells. The partial reduction of
CD40L in CD28-knockout (KO) mice is consistent with recent observations by others (26). Since no difference is observed between CD28-deficient mice and those deficient
for both HSA and CD28, it is unlikely that the suboptimal
induction of CD40L can be responsible for the severe defects in DNP-specific Ig class switches in the HSA-CD28 double-deficient mice.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 4.
Induction of CD40L
on CD4 T cells from wild-type
(WT), CD28-KO, HSA-KO,
and CD28/HSA double KO.
Spleen cells from each strain of
mice were incubated with 0.1 µg/ml of anti-CD3 mAb at
37°C for 2 h in the presence of 1 µg/ml of PE-labeled anti-CD40L (MR-1) in the presence
of 100-fold-excess of a control
mAb HB224. The spleen cells were then stained with FITC-conjugated
anti-CD4 mAb and analyzed by flow cytometry. Data presented were
histograms depicting CD40L expression of gated CD4 T cells (solid lines);
the autofluorescences of gated CD4 T cells in the absence of anti-CD40L
mAb were depicted in dotted lines.
|
|
We determined the number of cytokine producing cells
in the four congenic strains of mice, and the results from
five independent experiments are summarized in Fig. 5.
Targeted-mutations of both HSA and CD28 eliminated induction of KLH-specific IL-2 producers, IL-4 producers,
and IFN-
producers. Although CD28-deficiency caused a
threefold reduction in the number of IL-2-producing cells, it did not significantly affect the number of IL-4 and IFN-
producers. Targeted mutation of HSA had no significant
effect on the number of cytokine-producing cells. Given
the critical function of cytokine-producing cells in Ig class
switches, the reduction of the cytokine producers is likely
to be responsible for the lack of Ig class switches in mice
deficient for both HSA and CD28.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 5.
Quantitation of the number of (a) IL-2-, (b) IFN- - (WT),
and (c) IL-4-producing cells by ELISA spot. Mice were killed at one
month after the second immunization. Their spleen cells were cultured in
antibody-coated plates in the presence of 1 µg/ml of KLH for 16 h; after
lysis and washing away the cell debris, cytokine-producing spots were detected by biotinylated mAbs and HRP-conjugated avidin. T-depleted naive spleen cells from wild-type mice (2 × 105/well; WT) were treated
with mitomycin C and added to all wells as feeders. These feeder cells
(half-filled diamonds) do not contain cytokine producers as expected. In the
absence of antigen (unfilled crosses), no cytokine producing spot can be detected in primed wild-type mouse spleen. Data presented are summary of
five independent experiments with one to two spleens per group.
|
|
Taken together, we have demonstrated that for KLH-DNP, an antigen that can induce Ig class switches by a
CD28-independent mechanism, costimulation by either
HSA or CD28 is required for the induction of T cell help.
Although the CD28-independent IgG responses were not
observed in experiments using chicken gamma globulin as
carrier (2), they are substantial in CD28-deficient mice
when infected by viruses such as LCMV and VSV, and by
nematodes. Thus, two classes of antigens may exist: one requires CD28 to activate T helper cells, whereas the other
does not. The molecular basis for such distinction remains
to be determined. Given the recent findings by Kündig and
colleagues that CD28-mediated costimulation can be bypassed by prolonged exposure to antigen (28), one parameter that may distinguish two classes of antigens is their persistence in vivo.
How does repeated antigen stimulation bypass the requirement for costimulation by CD28? We have demonstrated that in the absence of CD28-B7 interaction, induction of memory CTL and elicitation of effector from
memory cells are not significantly affected, whereas induction of effector from naive T cells is abrogated (12). If the
conclusion is also applicable to CD4 T cell activation, this
suggests that the CD28-independent helper effectors are
not directly induced from naive T cells; rather, they are
elicited from memory cells induced by a HSA-dependent
mechanism. This requirement for restimulation would explain the need for persistent antigenic stimulation.
HSA- and CD28-mediated costimulatory pathways appear redundant in the sense that, for some antigens, each
can induce Ig class switches in the absence of the other.
However, the immunological mechanism for helper induction by the two pathways can be distinct. An important difference lies in their ability to induce germinal center formation: although costimulation by CD28 is necessary for
induction of germinal center (2), that by HSA is neither necessary nor sufficient (data not shown). Given the general requirement of germinal center for Ig hypermutation
and affinity maturation (29), it is unlikely that T cells costimulated by HSA can promote Ig hypermutation. Although
this may potentially limit the biological function of HSA-induced T helper cells, it should be noted that a recent
study by Kalinke et al. has demonstrated that high-affinity neutralizing IgG antibodies against VSV can be produced
without hypermutations (30).
Address correspondence to Yang Liu, Michael Heidelberger Division of Immunology, Department of Pathology and Kaplan Comprehensive Cancer Center, New York University Medical Center, 550 First Ave.,
New York, NY 10016. Phone: 212-263-7838; Fax: 212-263-8179; E-mail: liuy01{at}mcrcr6.med.nyu.edu
We thank Dr. Tak Mak for CD28-deficient mice and Dr. Peter J. Nielsen for HSA-deficient mice; John
Hirst for assistance in flow cytometry; and Fran Hitchcock for editorial assistance.
1.
|
Mueller, D.L.,
M.K. Jenkins, and
R.H. Schwartz.
1989.
Clonal expansion vs functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell
antigen occupancy.
Annu. Rev. Immunol.
7:
445-480
[Medline].
|
2.
|
Ferguson, S.E.,
S. Han,
G. Kelsoe, and
C.B. Thompson.
1996.
CD28 is required for germinal center formation.
J. Immunol.
156:
4576-4581
[Abstract/Free Full Text].
|
3.
|
Ronchese, F.,
B. Hausmann,
S. Hubele, and
P. Lane.
1994.
Mice transgenic for a soluble form of murine CTLA-4 show
enhanced expansion of antigen-specific CD4+ T cells and defective antibody production in vivo.
J. Exp. Med.
179:
809-817
[Abstract].
|
4.
|
Gause, W.C.,
S.J. Chen,
R.J. Greenwald,
M.J. Halvorson,
P. Lu,
X.D. Xhou,
S.C. Morris,
K.P. Lee,
C.H. June,
F.D. Finkelman, et al
.
1997.
CD28-dependence of T cell differentiation of IL-4 production varies with particular type 2 immune response.
J. Immunol.
158:
4082-4087
[Abstract].
|
5.
|
Linsley, P.S.,
E.A. Clark, and
J.A. Ledbetter.
1990.
The T
cell antigen, CD28, mediates adhesion with B cells by interacting with the activation antigen B7.
Proc. Natl. Acad. Sci.
USA.
87:
5031-5035
[Abstract].
|
6.
|
Shahinian, A.,
K. Pfeffer,
K. Lee,
K.P. Kundig,
T.M. Kishihara,
A. Wakham,
K. Kawai,
P.S. Ohashi,
C.B. Thompson, and
T.W. Mak.
1993.
Differential T cell costimulatory requirements in CD28-deficient mice.
Science.
261:
609-612
[Medline].
|
7.
|
Zimmermann, C.,
P. Seiler,
P. Lane, and
R.M. Zinkernagel.
1997.
Anti-viral immune response in CTLA4-transgenic
mice.
J. Virol.
71:
1802-1807
[Abstract].
|
8.
|
Liu, Y.,
B. Jones,
K. Sullivan,
A. Aruffo,
P.S. Linsley, and
C.A. Janeway Jr..
1992.
The heat-stable antigen is a costimulatory molecule for CD4 T cells.
J. Exp. Med.
175:
437-445
[Abstract].
|
9.
|
Liu, Y.,
B. Jones,
W. Brady,
C.A. Janeway Jr., and
P.S. Linsley.
1992.
Costimulation for CD4 T cell growth: Co-operation of B7 and the heat-stable antigen.
Eur. J. Immunol.
22:
2855-2859
[Medline].
|
10.
|
Enk, A., and
S. Katz.
1994.
Heat-stable antigen is an important costimulatory molecule on epidermal Langerhans' cells.
J. Immunol.
152:
3264-3270
[Abstract/Free Full Text].
|
11.
|
De Bruijn, M.L.H.,
P.A. Peterson, and
M.R. Jackson.
1996.
Induction of heat-stable antigen expression by phagocytosis is
involved in in vitro activation of unprimed cytotoxic T lymphocytes by macrophages.
J. Immunol.
156:
2686-2692
[Abstract].
|
12.
|
Liu, Y.,
R. Wenger,
M. Zhou, and
P.J. Nielsen.
1997.
Distinct costimulatory molecules are required for the induction
of effector and memory cytotoxic T cell responses.
J. Exp.
Med.
185:
251-262
[Abstract/Free Full Text].
|
13.
|
Wang, Y.-C.,
L. Zhu,
R. McHugh,
K.W. Sell, and
P. Selvaraj.
1995.
Expression of heat-stable antigen on tumor cells
provides co-stimulation for tumor-specific T cell proliferation and cytotoxicity in mice.
Eur. J. Immunol.
25:
1163-1167
[Medline].
|
14.
|
Reiser, H., and
B. Benacerraf.
1989.
Costimulatory signal
provided by a B lymphoid cell line and its Ia-negative variant.
Proc. Natl. Acad. Sci. USA.
86:
10069-10073
[Abstract].
|
15.
|
Li, Y.,
K.E. Hellstrom,
S.A. Newby, and
L. Chen.
1996.
Costimulation and B7-1 induces immunity to poorly immunogenic tumors.
J. Exp. Med.
183:
639-644
[Abstract].
|
16.
|
Guo, Y.,
Y. Wu,
S. Shinde, and
Y. Liu.
1996.
Identification
of a CD40 ligand-induced costimulatory molecule as CD44H.
J. Exp. Med.
184:
955-961
[Abstract].
|
17.
|
Dubey, C.,
M. Croft, and
S. Swain.
1995.
Costimulatory requirement of naive CD4 T cells: ICAM-1 or B7-1 can costimulate naive CD4 T cell activation, but both are required
for optimal responses.
J. Immunol.
155:
45-57
[Abstract].
|
18.
|
Shinde, S.,
Y. Wu,
Y. Guo,
J. Xu,
I.S. Grewal,
R.A. Flavell, and
Y. Liu.
1996.
CD40L is important for induction of, but
not response to, costimulatory activity: ICAM-1 as the second costimulatory molecule rapidly up-regulated by CD40L.
J. Immunol.
157:
2764-2768
[Abstract].
|
19.
|
DeBenedette, M.A.,
N.R. Chu,
K.E. Pollk,
J. Hurtodo,
W.F. Wade,
B.S. Kwon, and
T.H. Watts.
1995.
Role of 4-1BB
ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphoma by cAMP.
J. Exp. Med.
181:
985-992
[Abstract].
|
20.
|
Melero, I.,
W.W. Shuford,
S.A. Newby,
A. Aruffo,
J.A. Ledbetter,
K.E. Hellstrom,
R.S. Mittler, and
L. Chen.
1997.
Monoclonal antibodies against 4-1BB T cell activation molecule eradicate established tumors.
Nat. Med.
3:
682-685
[Medline].
|
21.
|
Nielsen, P.J.,
B. Lorenz,
A.M. Müller,
R.H. Wenger,
F. Brombacher,
M. Simon,
T. von der Weid,
W.J. Langhorne,
H. Mossmann, and
G. Köhler.
1997.
Altered erythrocytes and a
leaky block in B-cell development in CD24/HSA-deficient
mice.
Blood.
89:
1058-1067
[Abstract/Free Full Text].
|
22.
|
Wu, Y.,
Y. Guo,
C.A. Janeway Jr., and
Y. Liu.
1995.
Signalling by a new anti-Thy-1 monoclonal antibody interfere
with B7-2-mediated costimulation for T cell growth.
Cell.
Immunol.
165:
266-277
[Medline].
|
23.
|
Foy, T.M.,
A. Aruffo,
J. Bajorath,
J. Buhlmann, and
R.J. Noelle.
1996.
Immune regulation by CD40 and its ligand.
Annu.
Rev. Immunol.
14:
591-618
[Medline].
|
24.
|
Mosmann, T.R., and
R.L. Coffman.
1989.
Th1 and Th2
cells: different patterns of lymphokine secretion lead to different functional properties.
Annu. Rev. Immunol.
7:
145-173
[Medline].
|
25.
|
Finkelman, F.D.,
J. Holmes,
I.M. Katona,
J.F. Urban Jr.,
M.P. Beckmann,
L.S. Park,
K.A. Schooley,
R.L. Coffman,
T.R. Mosmann, and
W.E. Paul.
1990.
Lymphokine control
of in vivo immunoglobulin isotype selection.
Annu. Rev. Immunol.
8:
303-333
[Medline].
|
26.
|
Ihle, J.,
B.A. Witthuhn,
F.W. Quelle,
K. Yamamoto, and
O. Silvennoinen.
1995.
Signalling through the hematopoietic
cytokine receptors.
Annu. Rev. Immunol.
13:
369-398
[Medline].
|
27.
|
Ding, L.,
J.M. Green,
C.B. Thompson, and
E.M. Shevach.
1995.
B7/CD28-dependent and independent induction of
CD40 ligand expression.
J. Immunol.
155:
5124-5132
[Abstract].
|
28.
|
Kündig, M.,
A. Shahinian,
K. Kawai,
H.-W. Mittrücker,
E. Sebzda,
M.F. Bachmann,
T.W. Mak, and
P.S. Ohashi.
1996.
Duration of TCR stimulation determines costimulatory requirement of T cells.
Immunity.
5:
41-52
[Medline].
|
29.
|
MacLennan, I.C.M..
1994.
Germinal centers.
Annu. Rev. Immunol.
12:
117-139
[Medline].
|
30.
|
Kalinke, U.,
E.M. Bucher,
B. Ernst,
A. Oxenius,
H.P. Roost,
S. Geley,
R. Kofler,
R.M. Zinkernagel, and
H. Hengartner.
1996.
The role of somatic mutation in the generation of protective humoral immune response against vesicular stomatitis
virus.
Immunity
5:
639-652
[Medline].
|